King's College Criteria for Acetaminophen Toxicity
The KCC are a well-accepted criteria that show the degree of multiorgan dysfunction from acetaminophen-induced liver failure. Used alone or with serum lactate and phosphate, the KCC can predict patients with poor prognosis.
The King’s College Criteria (KCC) were developed to determine which patients with fulminant hepatic failure (FHF) should be referred for liver transplant.
- Apply to all (acute or chronic) acetaminophen ingestions with signs of severe acute liver injury.
- There are no worldwide standard criteria for transplantation, but the KCC are the most widely applied.
- The KCC indicators predict a poor prognosis, and select patients most likely to benefit from immediate liver transplant referral.
- The etiology of the acute liver failure is important in determining indicators of poor prognosis (acetaminophen vs. other causes).
- Metabolic acidosis alone OR combined grade III or IV hepatic encephalopathy AND a PT time > 100s AND creatinine > 3.4 mg/dL predicted 77% of total deaths.
Points to keep in mind:
- KCC is criticized for predicting mortality often when patients are too sick for transplant.
- The use of prolonged N-acetylcysteine therapy - not standard when the KCC was created - has significantly lowered the complication rate and need for transplant.
- PT values are often not comparable across laboratories (due to use of different reagents).
- Serum lactate (marker of liver injury), and phosphate (marker of liver regeneration), have been used as alternative early prognostic indicators or adjuncts to the KCC.
- Specific but not sensitive: that is, while fulfillment of the criteria carries a poor prognosis, lack of fulfillment can still carry an unfavorable outlook.
Acetaminophen poisoning is the most common cause of acute liver failure in the US, the UK and many other countries. The only treatment option that radically improves the outcome of acute liver failure is emergency liver transplantation. Therefore proper identification of which to refer/transfer is critically important.
In addition, appropriate transplant candidates must be identified as early as possible to provide a realistic window for a graft to become available.
Please fill out required fields.
About the Creator
John O’Grady, MD, is a professor of hepatology at King’s College Hospital and Chairman of UK Transplant Liver Advisory Group. His interests include outcomes after liver transplantation, optimal immunosuppression via clinical trials and the impact of recurrent disease on long-term outcome. Dr. O’Grady has published about clinical aspects of liver transplantation and acute liver failure.
To view Dr. John O'Grady's publications, visit PubMed
- Vince Nguyen, MD